Skip to main content
NCBI home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
. 1993 Nov;18(5):209–213.

Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.

B E Murphy 1, D Filipini 1, A M Ghadirian 1
PMCID: PMC1188541  PMID: 8297920

Abstract

The rationale for the use of anti-glucocorticoids in the treatment of major depression has been reviewed. Four patients with chronic severe depression who were resistant to conventional therapies were given RU 486 (200 mg/day) for periods up to eight weeks. Substantial levels of RU 486 were achieved within the first few days, and the levels fell gradually over the week after the treatment was discontinued. In three cases, treatment was stopped before the eight weeks were completed: in one case because of the appearance of a rash, in the others because of side-effects, which, in retrospect, were likely unrelated to the drug. The mean scores on the Hamilton Rating Scale for Depression of three patients decreased. Levels of adrenocorticotrophin, dehydroepiandrosterone and cortisol rose during treatment. These preliminary results suggest that glucocorticoid antagonists may be effective in the treatment of major depression and merit further exploration.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertagna X., Bertagna C., Luton J. P., Husson J. M., Girard F. The new steroid analog RU 486 inhibits glucocorticoid action in man. J Clin Endocrinol Metab. 1984 Jul;59(1):25–28. doi: 10.1210/jcem-59-1-25. [DOI] [PubMed] [Google Scholar]
  2. Gagne D., Pons M., Philibert D. RU 38486: a potent antiglucocorticoid in vitro and in vivo. J Steroid Biochem. 1985 Sep;23(3):247–251. doi: 10.1016/0022-4731(85)90401-7. [DOI] [PubMed] [Google Scholar]
  3. Gormley G. J., Lowy M. T., Reder A. T., Hospelhorn V. D., Antel J. P., Meltzer H. Y. Glucocorticoid receptors in depression: relationship to the dexamethasone suppression test. Am J Psychiatry. 1985 Nov;142(11):1278–1284. doi: 10.1176/ajp.142.11.1278. [DOI] [PubMed] [Google Scholar]
  4. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kettel L. M., Murphy A. A., Mortola J. F., Liu J. H., Ulmann A., Yen S. S. Endocrine responses to long-term administration of the antiprogesterone RU486 in patients with pelvic endometriosis. Fertil Steril. 1991 Sep;56(3):402–407. doi: 10.1016/s0015-0282(16)54531-2. [DOI] [PubMed] [Google Scholar]
  6. Krishnan K. R., Reed D., Wilson W. H., Saunders W. B., Ritchie J. C., Nemeroff C. B., Carroll B. J. RU486 in depression. Prog Neuropsychopharmacol Biol Psychiatry. 1992;16(6):913–920. doi: 10.1016/0278-5846(92)90109-r. [DOI] [PubMed] [Google Scholar]
  7. Murphy B. E., Dhar V., Ghadirian A. M., Chouinard G., Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol. 1991 Apr;11(2):121–126. [PubMed] [Google Scholar]
  8. Murphy B. E. Steroids and depression. J Steroid Biochem Mol Biol. 1991 May;38(5):537–559. doi: 10.1016/0960-0760(91)90312-s. [DOI] [PubMed] [Google Scholar]
  9. Murphy B. E. Treatment of major depression with steroid suppressive drugs. J Steroid Biochem Mol Biol. 1991 Aug;39(2):239–244. doi: 10.1016/0960-0760(91)90069-h. [DOI] [PubMed] [Google Scholar]
  10. Nieman L. K., Chrousos G. P., Kellner C., Spitz I. M., Nisula B. C., Cutler G. B., Merriam G. R., Bardin C. W., Loriaux D. L. Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. 1985 Sep;61(3):536–540. doi: 10.1210/jcem-61-3-536. [DOI] [PubMed] [Google Scholar]
  11. Peiffer A., Veilleux S., Barden N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology. 1991;16(6):505–515. doi: 10.1016/0306-4530(91)90034-q. [DOI] [PubMed] [Google Scholar]
  12. Sapolsky R. M., Krey L. C., McEwen B. S. Stress down-regulates corticosterone receptors in a site-specific manner in the brain. Endocrinology. 1984 Jan;114(1):287–292. doi: 10.1210/endo-114-1-287. [DOI] [PubMed] [Google Scholar]
  13. Whalley L. J., Borthwick N., Copolov D., Dick H., Christie J. E., Fink G. Glucocorticoid receptors and depression. Br Med J (Clin Res Ed) 1986 Mar 29;292(6524):859–861. doi: 10.1136/bmj.292.6524.859. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Medical Association

RESOURCES